vimarsana.com

Latest Breaking News On - Royalty pharma daily - Page 8 : vimarsana.com

Koshinski Asset Management Inc Cuts Position in Royalty Pharma plc (NASDAQ:RPRX)

Koshinski Asset Management Inc Cuts Position in Royalty Pharma plc (NASDAQ:RPRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Royalty Pharma plc (RPRX) to Issue Quarterly Dividend of $0 20 on December 15th

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) declared a quarterly dividend on Monday, October 16th, Zacks reports. Stockholders of record on Friday, November 17th will be paid a dividend of 0.20 per share by the biopharmaceutical company on Friday, December 15th. This represents a $0.80 annualized dividend and a dividend yield of 2.95%. The […]

Royalty Pharma plc (RPRX) To Go Ex-Dividend on November 16th

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) announced a quarterly dividend on Monday, October 16th, Zacks reports. Shareholders of record on Friday, November 17th will be given a dividend of 0.20 per share by the biopharmaceutical company on Friday, December 15th. This represents a $0.80 annualized dividend and a yield of 2.95%. The ex-dividend […]

Fjarde AP Fonden Fourth Swedish National Pension Fund Trims Stock Position in Royalty Pharma plc (NASDAQ:RPRX)

Fjarde AP Fonden Fourth Swedish National Pension Fund lessened its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 32.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,950 shares of the biopharmaceutical company’s stock […]

Fjarde AP Fonden Fourth Swedish National Pension Fund Trims Holdings in Royalty Pharma plc (NASDAQ:RPRX)

Fjarde AP Fonden Fourth Swedish National Pension Fund decreased its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 32.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,950 shares of the biopharmaceutical company’s stock after selling 43,600 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.